Showing results (71-80 of 127) with videos related to
Sort By:
Pageof 13
Plos One|May 21, 2010
Second generation sequencing of the mesothelioma tumor genomeRaphael Bueno, Assunta De Rienzo, Lingsheng Dong, et al.Archives of Pathology & Laboratory Medicine|August 6, 2009
Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest GroupAliya N Husain, Thomas V Colby, Nelson G Ordóñez, et al.The American Journal of Pathology|May 22, 2010
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasisElisa Benedettini, Lynette M Sholl, Michael Peyton, et al.Proceedings of the National Academy of Sciences of the United States of America|February 28, 2008
Transcriptome sequencing of malignant pleural mesothelioma tumorsDavid J Sugarbaker, William G Richards, Gavin J Gordon, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2015
The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 ClassificationWilliam D Travis, Elisabeth Brambilla, Andrew G Nicholson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALKAlice T Shaw, Beow Y Yeap, Mari Mino-Kenudson, et al.Nature Medicine|November 26, 2008
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancersJeffrey A Engelman, Liang Chen, Xiaohong Tan, et al.Cancer Research|May 19, 2007
Mutations in BRAF and KRAS converge on activation of the mitogen-activated protein kinase pathway in lung cancer mouse modelsHongbin Ji, Zhenxiong Wang, Samanthi A Perera, et al.Cancer Cell|May 30, 2006
The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapiesHongbin Ji, Danan Li, Liang Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2009
Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancerJian Yu, Susan Kane, Jiong Wu, et al.Pageof 13